Meeting
2020 Gastrointestinal Cancers Symposium
CD3+ tumor-infiltrating lymphocytes (TILs) as prognostic in patients (pts) with stage II colon cancer (CC) not treated with adjuvant chemotherapy (ADJ).
Authors
Edoardo Francini
Misericordia Hospital, Grosseto, Italy
Edoardo Francini , Fang-Shu Ou , Stefano Lazzi , Roberto Petrioli , Andrea Giovanni Multari , Guido Pesola , Luciana Messuti , Elena Colombo , Virginia Livellara , Serena Bazzurri , Sara Cherri , Miano Salvatora , Eric Wolfe , Steven R Alberts , Joleen Marie Hubbard , Harry H. Yoon , Guido Francini
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Anal and Colorectal Cancer
Track
Colorectal Cancer,Anal Cancer
Sub Track
Translational Research
Citation
J Clin Oncol 38, 2020 (suppl 4; abstr 167)
Abstract #
167
Poster Bd #
H9
Abstract Disclosures
Similar Posters
Poster
2020 Gastrointestinal Cancers Symposium
The influence of adjuvant chemotherapy dose intensity on overall survival in resected colon cancer: A multicenter retrospective analysis.
First Author: Suganija Lakkunarajah
Poster
2020 Gastrointestinal Cancers Symposium
Circulating tumor DNA-based decision for adjuvant treatment in colon cancer stage II evaluation: (CIRCULATE-trial) AIO-KRK-0217.
First Author: Gunnar Folprecht
Poster
2019 Gastrointestinal Cancers Symposium
Outcomes and utilization of adjuvant chemotherapy (AT) for stage II colon cancer (CC-II) in elderly population.
First Author: Afsaneh Barzi
Poster
2018 Gastrointestinal Cancers Symposium
Early survival outcomes in stage I-III operated colon cancer patients from a low prevalence, lower-middle income country: The Indian experience.
First Author: Rushabh Kiran Kothari